Living Cell Technologies (LCT)

0.009
0.000(0.00%)
  • Volume:
    3,133,371
  • Bid/Ask:
    0.008/0.009
  • Day's Range:
    0.009 - 0.009

LCT Overview

Prev. Close
0.009
Day's Range
0.009-0.009
Revenue
150K
Open
0.009
52 wk Range
0.005-0.013
EPS
0
Volume
3,133,371
Market Cap
11.57M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
3,901,469
P/E Ratio
-
Beta
1.15
1-Year Change
-21.51%
Shares Outstanding
1,285,363,723
Next Earnings Date
-
What is your sentiment on Living Cell Technologies?
or
Market is currently closed. Voting is open during market hours.

Living Cell Technologies Company Profile

Living Cell Technologies Company Profile

Employees
0
Market
Australia

Living Cell Technologies Limited is a biotechnology company. The Company is focused on discovering and developing treatments for conditions, such as diabetes and Parkinson’s disease. It operates in both Australia and New Zealand, being the research and development and product development into living cell technologies. The Company's product candidate includes NTCELL. NTCELL, an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells targeting Parkinson’s disease. Choroid plexus cells are naturally occurring support cells for the brain and secrete cerebrospinal fluid (CSF), which contains a range of factors that support nerve cell functions and protective enzymes that are crucial for nerve growth and healthy functioning. In NTCELL, the porcine choroid plexus cells are coated with LCT’s propriety technology IMMUPEL to protect them from attack by the immune system. The Company has completed two clinical trials of NTCELL in Parkinson's disease.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellNeutralSell
Technical IndicatorsNeutralNeutralBuyStrong BuySell
SummaryNeutralNeutralNeutralBuySell